Iomai Launches Phase 2 Clinical Study Of Vaccine Patch For Travelers' Diarrhea
Wed, 16 Aug 2006 07:00 AM EST
... Iomai Corporation(Nasdaq: IOMI) announced today that it has begun enrollment of a Phase 2trial designed to test its vaccine patch for travelers' diarrhea involunteers traveling to sites in Mexico and Guatemala. The field test willprovide the investigators with the crucial information needed to launch aPhase 3 trial of the needle-free vaccine. [click link for full article] ...
Related Topics
- Clinical Trials
- Diarrhea
- Vaccine
- Polio Vaccine & Cancer
- Polio Vaccine
- Polio Vaccine & Origin of HIV/AIDS
- Rotavirus
- Vaccine Side Effects
- Fentanyl Skin Patches
- Pharmacology
- MMR Vaccine & (Asceptic) Meningitis
- Smallpox Vaccine
- Psychopharmacology
- Chickenpox Vaccine
- Hepatitis A Vaccine
- Hepatitis A and Hepatitis B Vaccine
- Lidocaine Transdermal
- Hepatitis B Vaccine
- Pneumococcal Vaccine
- Estradiol Transdermal System

Not Signed In -

